Glycogen Synthase Association with the Striated Muscle Glycogen-targeting Subunit of Protein Phosphatase-1

Jun Liu, David L. Brautigan

Journal of Biological Chemistry · 2000 · 54 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Glycogen-binding subunits for protein phosphatase-1 (PP1) target the PP1 catalytic subunit (PP1C) to glycogen particles, where the enzymes glycogen synthase and glycogen phosphorylase are concentrated. Here we identify sites within the striated muscle glycogen-binding subunit (GM) that mediate direct binding to glycogen synthase. Both PP1C and glycogen synthase were coimmunoprecipitated with a full-length FLAG-tagged GM transiently expressed in COS7 cells or C2C12 myotubes. Deletion and mutational analysis of a glutathioneS-transferase (GST) fusion of the N-terminal domain of GM (residues 1–240) identified two putative sites for binding to glycogen synthase, one of which is the WXNXGXNYX(I/L) motif that is conserved among the family of PP1 glycogen-binding subunits. Either deletion of this motif or Ala substitution of Asn-228 in this motif disrupted the binding of glycogen synthase. Expression of full-length FLAG-GM in cells increased the activity of endogenous glycogen synthase, but protein disabled in either PP1 binding or glycogen synthase binding did not produce synthase activation. The results show that efficient activation of glycogen synthase requires a scaffold function of GM that involves simultaneous binding of both PP1C and glycogen synthase. Isoproterenol and forskolin treatment of cells decreased glycogen synthase binding to FLAG-GM, thereby limiting synthase activation by PP1. This response was insensitive to inhibition by H-89, therefore probably not involving cAMP-dependent protein kinase, but did require inclusion of microcystin-LR during cell lysis, implying that phosphorylation was modulating binding of glycogen synthase. Phosphorylation control of binding to a scaffold site on the GM subunit of PP1 offers a new mechanism for regulation of muscle glycogen synthase in response to β-adrenergic signals. Glycogen-binding subunits for protein phosphatase-1 (PP1) target the PP1 catalytic subunit (PP1C) to glycogen particles, where the enzymes glycogen synthase and glycogen phosphorylase are concentrated. Here we identify sites within the striated muscle glycogen-binding subunit (GM) that mediate direct binding to glycogen synthase. Both PP1C and glycogen synthase were coimmunoprecipitated with a full-length FLAG-tagged GM transiently expressed in COS7 cells or C2C12 myotubes. Deletion and mutational analysis of a glutathioneS-transferase (GST) fusion of the N-terminal domain of GM (residues 1–240) identified two putative sites for binding to glycogen synthase, one of which is the WXNXGXNYX(I/L) motif that is conserved among the family of PP1 glycogen-binding subunits. Either deletion of this motif or Ala substitution of Asn-228 in this motif disrupted the binding of glycogen synthase. Expression of full-length FLAG-GM in cells increased the activity of endogenous glycogen synthase, but protein disabled in either PP1 binding or glycogen synthase binding did not produce synthase activation. The results show that efficient activation of glycogen synthase requires a scaffold function of GM that involves simultaneous binding of both PP1C and glycogen synthase. Isoproterenol and forskolin treatment of cells decreased glycogen synthase binding to FLAG-GM, thereby limiting synthase activation by PP1. This response was insensitive to inhibition by H-89, therefore probably not involving cAMP-dependent protein kinase, but did require inclusion of microcystin-LR during cell lysis, implying that phosphorylation was modulating binding of glycogen synthase. Phosphorylation control of binding to a scaffold site on the GM subunit of PP1 offers a new mechanism for regulation of muscle glycogen synthase in response to β-adrenergic signals. protein phosphatase type-1 catalytic subunit of PP1 glutathioneS-transferase cAMP-dependent protein kinase epitope of sequence DYKDDDK striated muscle glycogen-binding subunit of PP1 fusion protein of GST plus N terminal 240 residues of GM epitope-tagged, full-length (1109 residues) version of GM liver-specific glycogen-binding subunit of PP1 protein targeting to glycogen subunit of PP1 Dulbecco's modified Eagle's medium polyacrylamide gel electrophoresis N-{2-[(p-bromocinnamyl)amino]ethyl}-5-isoquinolinesulphonamide hydrochloride Protein phosphatase-1 (PP1)1 is implicated in control of multiple cellular processes, including mitosis, muscle contraction, glycogen metabolism, protein synthesis, RNA splicing, and ion channel conductance (1Shenolikar S. Annu. Rev. Cell Biol. 1994; 10: 55-86Crossref PubMed Scopus (402) Google Scholar, 2Wera S. Hemmings B.A. Biochem. J. 1995; 311: 17-29Crossref PubMed Scopus (598) Google Scholar). Currently, it is thought that the individual functions are achieved by interaction of the PP1 catalytic subunit with various targeting/regulatory subunits. These subunits determine the subcellular location of subpopulations of the catalytic subunit of PP1. The first PP1 targeting subunit identified was the muscle glycogen-binding subunit, called GM or RGl, which tethers PP1 to glycogen particles and the sarcoplasmic reticulum in skeletal and cardiac muscle (3Hubbard M.J. Cohen P. Trends Biochem. Sci. 1993; 18: 172-177Abstract Full Text PDF PubMed Scopus (790) Google Scholar, 4Tang P.M. Bondor J.A. Swinderek K.M. DePaoli-Roach A.A. J. Biol. Chem. 1991; 266: 15782-15789Abstract Full Text PDF PubMed Google Scholar). This localization presumably facilitates the dephosphorylation of glycogen-metabolizing enzymes (3Hubbard M.J. Cohen P. Trends Biochem. Sci. 1993; 18: 172-177Abstract Full Text PDF PubMed Scopus (790) Google Scholar). Recent studies identified separate domains in GM for interaction with PP1 and glycogen (5Wu J. Liu J. Thompson I. Oliver C.J. Shenolikar S. Brautigan D.L. FEBS Lett. 1998; 439: 185-191Crossref PubMed Scopus (41) Google Scholar). PKA-catalyzed phosphorylation of Ser-67 in the PP1 binding motif (RVSF) has been shown to prevent PP1 binding to GM (6Hubbard M.J. Cohen P. Eur. J. Biochem. 1989; 180: 457-465Crossref PubMed Scopus (60) Google Scholar, 7Hubbard M.J. Cohen P. Eur. J. Biochem. 1989; 186: 701-709Crossref PubMed Scopus (101) Google Scholar), providing a mechanism by which the phosphatase would respond to β-adrenergic hormones such as adrenaline. Since the discovery of GM, several additional members of this protein family have been identified and cloned. Among these are the yeast homologue, GAC1 (8François J.M. Thompson-Jaeger S. Skroch J. Zellenka U. Spevak W. Tatchell K. EMBO J. 1992; 11: 87-96Crossref PubMed Scopus (126) Google Scholar), and a liver protein, GL (9Doherty M.J. Moorhead G. Morrice N. Cohen P. Cohen P.T. FEBS Lett. 1995; 375: 294-298Crossref PubMed Scopus (140) Google Scholar), which show significant sequence identity with the N-terminal region of GM. A search of the expressed sequence-tagged cDNA data base identified PPP1R5 (10Doherty M.J. Young P.R. Cohen P.T. FEBS Lett. 1996; 399: 339-343Crossref PubMed Scopus (90) Google Scholar) and PPP1R6 (11Armstrong C.G. Browne G.J. Cohen P. Cohen P.T. FEBS Lett. 1997; 418: 210-214Crossref PubMed Scopus (85) Google Scholar). A yeast two-hybrid screen of cDNA libraries using PP1C as the bait identified another two glycogen-binding proteins, U5 (12Hirano K. Hirano M. Hartshorne D.J. Biochim. Biophys. Acta. 1997; 1339: 177-180Crossref PubMed Scopus (8) Google Scholar) and PTG (13Printen J.A. Brady M.J. Saltiel A.R. Science. 1997; 275: 1475-1478Crossref PubMed Scopus (241) Google Scholar). PTG is nearly identical to PPP1R5 and is expressed abundantly in insulin-sensitive tissues such as skeletal muscle, liver, heart, and differentiated adipocytes (13Printen J.A. Brady M.J. Saltiel A.R. Science. 1997; 275: 1475-1478Crossref PubMed Scopus (241) Google Scholar). In addition to associating with PP1 and glycogen, PTG functions as a scaffold that binds glycogen synthase, phosphorylase, and phosphorylase kinase (13Printen J.A. Brady M.J. Saltiel A.R. Science. 1997; 275: 1475-1478Crossref PubMed Scopus (241) Google Scholar), the substrates for PP1 in the glycogen particles. This raises the possibility that other members of the PP1 glycogen-binding subunit family also fulfill a scaffolding role by directly interacting with PP1 substrates. Sequence comparison of six eucaryotic glycogen-binding subunits of PP1 and two yeast glycogen synthase-binding proteins, Pig1p and Pig2p (14Cheng C. Huang D. Roach P.J. Yeast. 1997; 13: 1-8Crossref PubMed Scopus (29) Google Scholar), revealed two regions of conserved sequence. One is a VXNXXFEKXV motif that we found directly involved in glycogen binding (5Wu J. Liu J. Thompson I. Oliver C.J. Shenolikar S. Brautigan D.L. FEBS Lett. 1998; 439: 185-191Crossref PubMed Scopus (41) Google Scholar). The other is a region of 15 residues with conserved residues Trp, Asn, Gly, Asn, Tyr, and Leu/Ile that we designate as the WXNXGXNYX(L/I) motif. However, no experimental evidence for a function for this motif is available. In this study, we examined the binding of glycogen synthase with deletion and point mutants of GM and identified specific regions in GM that interact with glycogen synthase. Ala substitution of residues in the WXNXGXNYX(L/I) motif showed that substitution of Asn-228 impaired glycogen synthase binding but did not alter PP1 binding. Expression of GM mutants deficient in either glycogen synthase binding or PP1 binding failed to activate glycogen synthase in cells, compared with wild type GM, suggesting that GM interaction with both PP1 and glycogen synthase is required for activation of glycogen synthase. Furthermore, stimulation of cells with forskolin and isoproterenol decreased the binding of glycogen synthase to wild type GM but in a PKA-independent manner. Results obtained with various mutated forms of GM suggest that the effects are mediated through change in phosphorylation of glycogen synthase, exposing a new mechanism for regulation by β-adrenergic signals in muscle. Tissue culture reagents and the kit for reverse-transcription (Preamplification System for first strand cDNA synthesis) were purchased from Life Technologies (Grand Island, NY). pGEX vectors and glutathione-Sepharose were purchased from Amersham Pharmacia Biotech (Piscataway, NJ). [U-14C]uridine diphosphoglucose ([U-14C]UDPG) was purchased from NEN Life Science Products (Boston, MA). Isoproterenol, propranolol, H-89, and microcystin-LR was purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA). Forskolin, leupeptin, and aprotinin were from Sigma (St. Louis, MO). Pefabloc was purchased from Roche Molecular Biochemicals (Indianapolis, IN). Mouse anti-PP1 monoclonal antibodies were purchased from Transduction Laboratories (Lexington, KY). Dr. J. C. Lawrence, Jr. generously provided chick anti-glycogen synthase polyclonal antibodies and purified glycogen synthase. GM antisera were generated by immunizing rabbits with recombinant GST-GM-(1–240) 2The numbers in parenthesis indicate the residues of rabbit GM that were fused to GST. fusion protein. Restriction enzymes were from Promega Life Science (Madison, WI). All the oligonucleotides were synthesized by ITD (Coralville, IA). Rabbit cDNA encoding GM-(1–240) was cloned and inserted into pGEX4T2 vector to produce recombinant GST-GM-(1–240) fusion protein as described before (15Wu J. Kleiner U. Brautigan D.L. Biochemistry. 1996; 35: 13858-13864Crossref PubMed Scopus (30) Google Scholar). The GM-(1–240) fragment was then subcloned into pCDNA3/F2 mammalian expression vector byBamHI/EcoRI double digestion to produce FLAG-tagged GM-(1–240) protein. The entire sequence of rabbit GM was cloned into and pCDNA3/F2 vectors by and as described J. J. Oliver C. Shenolikar S. Brautigan D.L. Biochem. J. PubMed Scopus Google Scholar). Deletion mutants of GM and point in GM-(1–240) were using the described (15Wu J. Kleiner U. Brautigan D.L. Biochemistry. 1996; 35: 13858-13864Crossref PubMed Scopus (30) Google J. J. Oliver C. Shenolikar S. Brautigan D.L. Biochem. J. PubMed Scopus Google Scholar). in full-length GM were by using a kit to the were by COS7 cells were in new C2C12 were in which point was by to with Cell fusion was COS7 cells were of for 15 to treatment with using C2C12 were for in with and COS7 cells and C2C12 in were to and by to the Molecular was transiently for in the COS7 cells were then for the C2C12 were to by to with for This of GST-GM-(1–240) protein to glutathione-Sepharose to glycogen synthase and PP1C from COS7 cell as described (15Wu J. Kleiner U. Brautigan D.L. Biochemistry. 1996; 35: 13858-13864Crossref PubMed Scopus (30) Google Scholar). the of purified glycogen synthase, of GST-GM-(1–240) protein to glutathione-Sepharose was with glycogen synthase for in of binding The binding of glycogen synthase and PP1 was by anti-glycogen synthase and anti-PP1 Cell were by in a leupeptin, for with of for cells in The cell were by for were by of cell with of gel for The were with the and then to on the gel were to which were then in and were with the antibodies and as described (15Wu J. Kleiner U. Brautigan D.L. Biochemistry. 1996; 35: 13858-13864Crossref PubMed Scopus (30) Google Scholar). binding was by with synthase activity was as described Brady M.J. K. P. Saltiel A.R. J. Biol. Chem. 1995; 35: Scopus Google Scholar) with two with COS7 cells were into of synthase and as were by for of the cell was to of glycogen synthase and and 15 glycogen, in the or of 15 of were on for 15 The entire of the were on a which was in of then one with of for were and was with of glutathioneS-transferase (GST) to various regions of the N-terminal domain of GM expressed the fusion in and purified on A was to for binding of glycogen synthase and PP1C from of COS7 The glycogen synthase and PP1C that to fusion were by Both GST-GM-(1–240) and with glycogen synthase and GST and as a control The fusion protein the of the PP1C but not glycogen synthase, that the region was required for glycogen synthase binding. the other a fusion protein the failed to PP1C as but glycogen synthase the as to a protein that glycogen synthase to a and with was no glycogen synthase binding. showed that of the GST fusion was and the of COS7 cell protein was in These that binding of glycogen synthase involved two sites of residues and within the N-terminal domain of GM. In the region of GM is a WXNXGXNYX(L/I) motif of several residues conserved among the family of glycogen-binding subunits. This motif also in and two yeast in a two-hybrid screen using glycogen synthase as bait (14Cheng C. Huang D. Roach P.J. Yeast. 1997; 13: 1-8Crossref PubMed Scopus (29) Google Scholar). for the conserved residues with the to produce forms of and In the wild type and of glycogen synthase, but binding was with The of purified fusion protein was in shown by of the Ala PP1C binding in this suggesting that the of the various fusion was not evidence of the wild type GST-GM-(1–240) and the the during digestion with with the of the of glycogen synthase binding by Ala substitution not to of the protein. no significant in glycogen synthase binding was wild type GST-GM-(1–240) and a double that was shown to have glycogen binding in a (5Wu J. Liu J. Thompson I. Oliver C.J. Shenolikar S. Brautigan D.L. FEBS Lett. 1998; 439: 185-191Crossref PubMed Scopus (41) Google Scholar). that glycogen synthase binding did not on glycogen binding to GM. these results that Asn-228 in the WXNXGXNYX(L/I) motif a role in glycogen synthase binding. Furthermore, sites were by GM to interact with glycogen, with and with glycogen synthase. using cell as a of glycogen synthase, we binding of purified skeletal muscle glycogen synthase to GST-GM-(1–240) to a direct interaction the synthase was with GST or in the synthase GST-GM-(1–240) but did not to GST or This data with COS7 as the of glycogen synthase. of GST were in the as in this was to binding by of glycogen synthase with GST or The of glycogen synthase was by The of glycogen synthase to GST-GM-(1–240) was for by the to GST and in by using within the response of the glycogen synthase GST-GM-(1–240) with of glycogen synthase in this with a of that the substitution Asn-228 Ala in GST-GM-(1–240) a in the for glycogen synthase. expressed the FLAG-tagged domain in COS7 cells and examined glycogen synthase using the antibodies and anti-glycogen synthase were either with vector or with a vector encoding wild type or All forms of expressed the with by glycogen synthase was coimmunoprecipitated with but not with or All these fusion to The results showed that the GM-(1–240) domain with glycogen synthase in cells and that the Asn-228 in the WXNXGXNYX(L/I) motif was cells were and the glycogen synthase activity was in the cell not the GM-(1–240) domain a activity of glycogen synthase and this increased by expression of However, expression of either or no significant on glycogen synthase activity The results showed that forms of that to glycogen synthase activation. also full-length (1109 residues) wild type FLAG-tagged and mutated in either the motif or the glycogen synthase-binding motif. and both glycogen synthase and as by The with PP1C but not glycogen synthase, and glycogen synthase but not PP1C and in cells interaction of with glycogen synthase was of PP1C binding. synthase activity was in cells various forms of Expression of the of glycogen synthase activity did the with This is the first of a of the region of GM (residues that is not conserved in other glycogen-binding subunits of PP1. synthase activity was increased to in cells either or Expression of disabled in PP1C such as and or in glycogen synthase such as effects on glycogen synthase that as a interacting with both glycogen synthase and PP1C to mediate the activation of glycogen synthase by that in cells of PP1C from by forskolin J. J. Oliver C. Shenolikar S. Brautigan D.L. Biochem. J. PubMed Scopus Google Scholar), a that in and COS7 cells transiently with of was of PP1C binding and 15 of forskolin was a in the of glycogen synthase to and 15 forskolin was in the of glycogen synthase by In COS7 cells with a β-adrenergic binding of PP1C and glycogen synthase to was decreased by results also were obtained with C2C12 a skeletal muscle cell However, the of isoproterenol on glycogen synthase binding and PP1C binding to was not the protein phosphatase microcystin-LR was to the cell was that phosphorylation glycogen synthase binding to and this phosphorylation by the of endogenous in the cell in activity was to binding of glycogen synthase to in of COS7 cells with H-89, a specific and cell the effects of forskolin on PP1C binding the phosphorylation of Ser-67 in However, addition of to cells did not prevent of glycogen synthase binding by This that phosphorylation of glycogen synthase by was not to binding of purified glycogen synthase to GST-GM-(1–240) was by phosphorylation of either of the not addition of to cells failed to isoproterenol of glycogen synthase binding to of cells with isoproterenol in the of propranolol, β-adrenergic both PP1C and glycogen synthase binding to This showed that of glycogen synthase from involved of β-adrenergic the activation of shown in and PP1C in COS7 J. J. Oliver C. Shenolikar S. Brautigan D.L. Biochem. J. PubMed Scopus Google Scholar), forskolin treatment of cells of PP1C binding to but did not PP1C binding to In no PP1C binding was with the and These forms of glycogen synthase the in the of of the of of cells with forskolin in a in glycogen synthase binding to of these FLAG-GM The of the sites of GM forskolin probably binding by phosphorylation of the glycogen effects on glycogen synthase with wild type and mutated cells were with forms of were and with or 15 forskolin for Cell were and was FLAG-GM and glycogen synthase and PP1C were by glycogen particles have been as where and enzymes are into with that are and J. Biol. Chem. Full Text PDF PubMed Google Scholar, J. Biol. Chem. Full Text PDF PubMed Google Scholar, J. Biol. Chem. Full Text PDF PubMed Google Scholar). of PP1C into muscle glycogen particles involves a glycogen-binding subunit called GM or (3Hubbard M.J. Cohen P. Trends Biochem. Sci. 1993; 18: 172-177Abstract Full Text PDF PubMed Scopus (790) Google Scholar, 4Tang P.M. Bondor J.A. Swinderek K.M. DePaoli-Roach A.A. J. Biol. Chem. 1991; 266: 15782-15789Abstract Full Text PDF PubMed Google Scholar) that PP1C in to the glycogen-metabolizing synthase is the in glycogen C. J. Biochim. Biophys. Acta. PubMed Scopus Google Scholar, Roach P.J. 1997; PubMed Google Scholar, P. P. The Scholar) and is a for PP1 activity (3Hubbard M.J. Cohen P. Trends Biochem. Sci. 1993; 18: 172-177Abstract Full Text PDF PubMed Scopus (790) Google Scholar, P. Cohen P. Eur. J. Biochem. PubMed Scopus Google Scholar, M.J. Cohen P. Eur. J. Biochem. 1989; 186: PubMed Scopus Google Scholar). The is to PP1C of the enzymes of glycogen glycogen synthase, phosphorylase, and phosphorylase kinase M.J. Cohen P. Eur. J. Biochem. 1989; 186: PubMed Scopus Google Scholar). The phosphatase activity was to a to the of both substrates with glycogen (3Hubbard M.J. Cohen P. Trends Biochem. Sci. 1993; 18: 172-177Abstract Full Text PDF PubMed Scopus (790) Google Scholar). However, studies in yeast with and Pig1p that with glycogen, were direct of these PP1 targeting subunits with substrates such as a of glycogen synthase in (14Cheng C. Huang D. Roach P.J. Yeast. 1997; 13: 1-8Crossref PubMed Scopus (29) Google Scholar). Furthermore, PTG was as another mammalian glycogen-binding subunit of PP1 and was shown to directly the PP1 glycogen synthase, phosphorylase, and phosphorylase kinase (13Printen J.A. Brady M.J. Saltiel A.R. Science. 1997; 275: 1475-1478Crossref PubMed Scopus (241) Google Scholar). on these we that other members of the family of mammalian PP1 glycogen-binding GM, would directly enzymes involved in glycogen to with Here we evidence that GM with PP1C and glycogen synthase, in the of The glycogen interaction motif in GM not to involved in the with glycogen synthase, the double that did not glycogen (5Wu J. Liu J. Thompson I. Oliver C.J. Shenolikar S. Brautigan D.L. FEBS Lett. 1998; 439: 185-191Crossref PubMed Scopus (41) Google Scholar) did glycogen synthase to the as the wild type protein. The other family members PTG and GL glycogen phosphorylase (13Printen J.A. Brady M.J. Saltiel A.R. Science. 1997; 275: 1475-1478Crossref PubMed Scopus (241) Google Scholar, C.G. M.J. Cohen P.T. Biochem. J. 1998; PubMed Scopus Google Scholar). However, in with and GST-GM-(1–240) we did not a specific interaction Sequence comparison that the phosphorylase domain in GL is not conserved in GM (9Doherty M.J. Moorhead G. Morrice N. Cohen P. Cohen P.T. FEBS Lett. 1995; 375: 294-298Crossref PubMed Scopus (140) Google Scholar, C.G. M.J. Cohen P.T. Biochem. J. 1998; PubMed Scopus Google Scholar). binding of GM and family members such as GL and that binding of glycogen synthase to GM is generated by the interaction of glycogen synthase with two sites (residues and of either site a of glycogen synthase binding in a GST that the region of GM, the WXNXGXNYX(L/I) was required for glycogen synthase binding. a Ala substitution of Asn-228 in this motif also was to prevent binding of glycogen synthase to GM. This to suggest that the WXNXGXNYX(L/I) motif is the or site for Sequence showed that the WXNXGXNYX(L/I) motif was conserved among the subunits and the yeast glycogen synthase binding proteins, and (14Cheng C. Huang D. Roach P.J. Yeast. 1997; 13: 1-8Crossref PubMed Scopus (29) Google Scholar). However, this motif not for glycogen synthase a protein with the sequence fused to GST did not glycogen synthase not a for the N-terminal domain of GM has been on to the which has M. N. I. Protein Sci. PubMed Scopus Google Scholar). The has with for binding PP1C and a with the residues for binding to sites for interaction with glycogen synthase would in the putative and WXNXGXNYX(L/I) and a and that (residues that these two sites are on one of the from the site for interaction with glycogen and separate from the for binding to data show that PP1C and glycogen synthase both to GM in for GM to mediate activation of glycogen synthase. GM PP1 activity glycogen synthase by PP1C and glycogen synthase into the protein direct binding. This also in the catalytic subunit the to or In this the scaffold subunit (GM) would function as the that direct binding of substrates to targeting subunits a mechanism to of the PP1 catalytic subunit in is the muscle phosphatase targeting subunit that with and two regions in the subunit were to for binding M. K. S. M. M. Hirano K. Hartshorne D.J. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar, Cohen P. Cohen P.T. Eur. J. Biochem. 1997; PubMed Scopus Google Scholar). These of PP1C for as new PP1 targeting/regulatory subunits have been but the substrates for these PP1 are not to specific cellular with of these subunits. then and the binding sites on the PP1 subunits we have of the and activity of PP1 is in we of function with a substitution target and the a and a subunit glycogen synthase and This would a of the of and the of PP1 substrates. results also a mechanism for glycogen synthase by β-adrenergic signals. evidence that β-adrenergic or of by forskolin glycogen synthase binding to GM. was required in the implying that a phosphorylation for the change and was a dephosphorylation by of the synthase from to by phosphorylation of glycogen synthase that was but to of studies that phosphorylation and of muscle glycogen synthase by β-adrenergic hormones involved J. Biol. Chem. Full Text PDF PubMed Google Scholar, C. J. Hemmings Cohen P. FEBS Lett. PubMed Scopus Google Scholar, P.J. J. PubMed Scopus Google Scholar, C. Cohen P. FEBS Lett. PubMed Scopus Google Scholar). However, another showed that of muscle glycogen synthase, not a increased from to in response to S. Cohen P. Eur. J. Biochem. 1991; PubMed Scopus Google Scholar). phosphorylation of by phosphorylase kinase, phosphorylation of by kinase glycogen synthase activity by S. Cohen P. Eur. J. Biochem. 1991; PubMed Scopus Google Scholar). However, the activity of kinase was by in or by with and in one possibility is that glycogen synthase for GM is by phosphorylation of by other or of effects through also has PKA-independent including binding directly to cardiac and other ion and to J. 1998; PubMed Scopus Google Scholar, N. S. M. M. Science. 1998; PubMed Scopus Google Scholar, S. P. N. M. Sci. U. S. 1998; PubMed Scopus Google Scholar). has been that signals by and in a PKA-independent J.M. M.J. Biol. PubMed Scopus Google Scholar). the site of phosphorylation in glycogen synthase that for GM and the kinase that the phosphorylation are for that β-adrenergic but not glycogen synthase with targeting sites in GM that binding to GM would a to the phosphorylation and activity of glycogen synthase. This mechanism another to the for glycogen synthase, in addition to the phosphorylation and binding of Dr. C. Lawrence, Jr. for the of purified glycogen synthase, antibodies to glycogen synthase, and for and also to for in the and for

References

31